In contrast, our results showed that GLS2 is over-expressed in bladder and lung cancers [55,56], whereas it is downregulated in liver cancer [57] which indicates that glutaminases are indeed differentially expressed in different types of human cancer. The gene discussed is GLS; the disease is liver cancer.